Your browser doesn't support javascript.
loading
A subset of type-II collagen-binding antibodies prevents experimental arthritis by inhibiting FCGR3 signaling in neutrophils.
Xu, Zhongwei; Xu, Bingze; Lundström, Susanna L; Moreno-Giró, Àlex; Zhao, Danxia; Martin, Myriam; Lönnblom, Erik; Li, Qixing; Krämer, Alexander; Ge, Changrong; Cheng, Lei; Liang, Bibo; Tong, Dongmei; Stawikowska, Roma; Blom, Anna M; Fields, Gregg B; Zubarev, Roman A; Holmdahl, Rikard.
Afiliação
  • Xu Z; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Xu B; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Lundström SL; Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Moreno-Giró À; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Zhao D; Redoxis AB, Lund, Sweden.
  • Martin M; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Lönnblom E; Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Li Q; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Krämer A; Center for Medical Immunopharmacology Research, Southern Medical University, Guangzhou, China.
  • Ge C; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Cheng L; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Liang B; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Tong D; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Stawikowska R; Center for Medical Immunopharmacology Research, Southern Medical University, Guangzhou, China.
  • Blom AM; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Fields GB; Institute for Human Health & Disease Intervention and Department of Chemistry & Biochemistry, Florida Atlantic University, Jupiter, FL, USA.
  • Zubarev RA; Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Holmdahl R; Institute for Human Health & Disease Intervention and Department of Chemistry & Biochemistry, Florida Atlantic University, Jupiter, FL, USA.
Nat Commun ; 14(1): 5949, 2023 09 23.
Article em En | MEDLINE | ID: mdl-37741824

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Experimental Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Experimental Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article